Search Results - "De Campos, J. M."

Refine Results
  1. 1
  2. 2

    Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations by Arjona, D., Bello, M. J., Alonso, M. E., Aminoso, C., Isla, A., De Campos, J. M., Sarasa, J. L., Gutierrez, M., Villalobo, A., Rey, J. A.

    Published in Neuropathology and applied neurobiology (01-08-2005)
    “…The epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein with tyrosine kinase activity. This report investigates the presence of mutations,…”
    Get full text
    Journal Article
  3. 3

    Mutation analysis of the p73 gene in nonastrocytic brain tumours by ALONSO, M. E, BELLO, M. J, GONZALEZ-GOMEZ, P, LOMAS, J, ARJONA, D, DE CAMPOS, J. M, KUSAK, M. E, SARASA, J. L, ISLA, A, REY, J. A

    Published in British journal of cancer (20-07-2001)
    “…Loss of heterozygosity (LOH) involving the distal chromosome 1 p36 region occurs frequently in nonastrocytic brain tumours, but the tumour suppressor gene…”
    Get full text
    Journal Article
  4. 4

    Frontal osteomas: standardising therapeutic indications by Gil-Carcedo, L M, Gil-Carcedo, E S, Vallejo, L A, de Campos, J M, Herrero, D

    Published in Journal of laryngology and otology (01-10-2011)
    “…We believe the currently accepted indications for frontal osteoma surgery are inappropriate. We propose a new osteoma classification system, below, in order to…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Camino® intracranial pressure monitor: prospective study of accuracy and complications by Martínez-Mañas, Rosa M, Santamarta, David, de Campos, José M, Ferrer, Enric

    “…OBJECTIVES The fibreoptic device is a type of intracranial pressure monitor which seems to offer certain advantages over conventional monitoring systems. This…”
    Get full text
    Journal Article
  8. 8

    NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas by LEONE, P. E, BELLO, M. J, DE CAMPOS, J. M, VAQUERO, J, SARASA, J. L, PESTANA, A, REY, J. A

    Published in Oncogene (01-04-1999)
    “…Formation of meningiomas and their progression to malignancy may be a multi-step process, implying accumulation of genetic mutations at specific loci. To…”
    Get full text
    Journal Article
  9. 9

    DAPK1 promoter hypermethylaiton in brain metastases and peripheral blood by Martinez-Glez, V, Franco-Hernandez, C, Gonzalez-Gomez, P, Isla, A, De Campos, J M, Vaquero, J, Gutierrez, M, Casartelli, C, Rey, J A

    Published in Neoplasma (2007)
    “…The DAPK1 gene works as a regulator of apoptosis and is frequently inactivated in cancer by aberrant promoter hypermethylation. Loss of DAPK1 expression is…”
    Get more information
    Journal Article
  10. 10

    Arachnoid cysts: entrapped collections of cerebrospinal fluid variably communicating with the subarachnoid space by Santamarta, D, Morales, F, Sierra, J M, de Campos, J M

    Published in Minimally invasive neurosurgery (01-09-2001)
    “…Despite decades of investigation and discussion of the mechanisms involved in the pathophysiology of arachnoid cysts, fundamental issues concerning these…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Y-Stent-Assisted Coil Embolization of Anterior Circulation Aneurysms Using Two Solitaire AB Devices: A Single Center Experience by Martínez-Galdámez, M., Saura, P., Saura, J., Martinez, A., De Campos, J.M., Pérez, A.

    Published in Interventional neuroradiology (01-06-2012)
    “…Wide-neck intracranial aneurysms remain a challenge to endovascular treatment. We describe our experience in repairing wide-neck aneurysms of the anterior…”
    Get full text
    Journal Article
  13. 13

    A semi-automated microscopic image analysis method for scoring Ki-67 nuclear immunostaining by Fernezlian, S.M, Baldavira, C.M, de Souza, M.L.F, Farhat, C, de Vilhena, A.F, Pereira, J.C.N, de Campos, J.R.M, Takagaki, T, Balancin, M.L, AbSaber, A.M, Capelozzi, V.L

    “…Nuclear proliferation marker MIB-1 (Ki-67) immunohistochemistry (IHC) is used to examine tumor cell proliferation. However, the diagnostic or prognostic value…”
    Get full text
    Journal Article
  14. 14

    Absence of mutation of the p73 gene in astrocytic neoplasms by Alonso, M E, Bello, M J, Lomas, J, Gonzalez-Gomez, P, Arjona, D, De Campos, J M, Gutierrez, M, Isla, A, Vaquero, J, Rey, J A

    Published in International journal of oncology (01-09-2001)
    “…In subgroups of astrocytic neoplasms, including glioblastoma (GBM), mutations of the p53 tumour suppressor gene lead to loss of growth-suppressive properties…”
    Get more information
    Journal Article
  15. 15

    O2.07 FIRST 100 VESTIBULAR SCHWANNOMAS TREATED WITH GAMMA KNIFE IN SPAIN: LONG-TERM OUTCOME by de Andres, P., Presti, A. L., Kusak, M. E., Martinez, N., de Campos, J. M., Martinez, R.

    Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)
    “…INTRODUCTION: Gamma Knife radiosurgery (GKRS) has become an established treatment option for vestibular schwannomas (VS). The aim of this study was to…”
    Get full text
    Journal Article
  16. 16

    P12.02 BRAINSTEM HEMANGIOBLASTOMAS IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE - SURGICAL CONSIDERATIONS by De Campos, J. M., Vinas, D., Aguirre, D., Kusak, M. E., Quijada, C., Montoya, J., Fortes, J.

    Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)
    “…BACKGROUND: Von Hippel-Lindau disease (VHL) predisposes to the development of CNS hemangioblastomas. Brainstem hemangioblastomas present in 15 to 30% of VHL…”
    Get full text
    Journal Article
  17. 17

    P13.17 STEREOTACTIC RADIOSURGERY WITH GAMMA KNIFE FOR NEUROFIBROMATOSIS 2-ASSOCIATED VESTIBULAR SCHWANNOMAS by Presti, A. L., De Andres, P., Kusak, M. E., De Campos, J. M., Martinez, N., Martinez, R.

    Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)
    “…BACKGROUND: It is though that Stereotactic Radiosurgery (SRS) is less effective in achieving local tumor control in Neurofibromatosis 2 (NF2)-related…”
    Get full text
    Journal Article
  18. 18

    O5.10 5-ALA FLUORESCENCE GUIDED RESECTION OF HEMANGIOBLASTOMAS - IS IT USEFUL WITH CONVENTIONAL SURGICAL TOOLS? by De Campos, J. M., Sainz, L., Presti, A. L., Ramirez, M., Aguirre, D., Ordonez, C., Daoud, L.

    Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)
    “…BACKGROUND: The use of 5-aminolevulinic acid (5-ALA) for fluorescent guided malignant glioma surgery has proved to be useful to ensure a complete resection and…”
    Get full text
    Journal Article
  19. 19
  20. 20

    P01.06 HIF-1 AND HIF-2 AS POSIBLE NEW TARGETS IN THE TREATMENT OF VON HIPPEL-LINDAU DISEASE HEMANGIOBLASTOMAS by Vinas, D., Serrano-Heras, G., Perona-Morata, A. B., De Andres, P., Fortes, J., Segura, T., De Campos, J. M.

    Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)
    “…BACKGROUND: Von Hippel-Lindau disease (VHL)is a genetic condition predisposing to the development of multiple specific tumors, mainly CNS and retinal…”
    Get full text
    Journal Article